Antibody to Human CD82 Conjugated to PE/Cy7

<strong>Antibody to Human CD82 Conjugated to PE/Cy7</strong>_x000D_ <strong>Catalog number:</strong> B2015556_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> PE/Cy7 anti-human CD82_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pavlasova G, Mraz M. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy Haematologica. 2020 Jun;105(6):1494-1506._x000D_ 2: Lee H, Han JH, An K, Kang YJ, Hwangbo H, Heo JH, Choi BH, Kim JJ, Kim SR, Lee SY, Hur J. Recombinant human KAI1/CD82 attenuates M1 macrophage polarization on LPS-stimulated RAW264.7 cells via blocking TLR4/JNK/NF-κB signal pathway BMB Rep. 2023 Jun;56(6):359-364._x000D_ 3: Zhang QH, Yao YL, Wu XY, Wu JH, Gu T, Chen L, Gu JH, Liu Y, Xu L. Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82 Dig Dis Sci. 2015 Jul;60(7):1967-76._x000D_ 4: Ma X, He X, Wang C, Huang X, Li Y, Ma K. Small extracellular ring domain is necessary for CD82/KAI1'anti-metastasis function Biochem Biophys Res Commun. 2021 Jun 11;557:110-116._x000D_ 5: Nishioka C, Ikezoe T, Yokoyama A. Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo Cancer Med. 2015 Sep;4(9):1426-31._x000D_ 6: Dai W, Wang C, Wang F, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Yang J, Zhu R, Zhang H, Li J, Zheng Y, Lu J, Zhou Y, Xu L, Guo C. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82 Biochem Biophys Res Commun. 2014 Apr 4;446(2):541-8._x000D_ 7: Wang H, Zhang W, Zhao J, Zhang L, Liu M, Yan G, Yao J, Yu H, Yang P. N-Glycosylation pattern of recombinant human CD82 (KAI1), a tumor-associated membrane protein J Proteomics. 2012 Feb 2;75(4):1375-85._x000D_ 8: Knoener M, Krech T, Puls F, Lehmann U, Kreipe H, Christgen M. Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancer Dis Markers. 2012;32(6):337-42._x000D_ 9: Zhang QH, Yao YL, Wu XY, Wu JH, Gu T, Chen L, Gu JH, Liu Y, Xu L. Erratum to: Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82 Dig Dis Sci. 2015 Aug;60(8):2544._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/27103437">10: Nomura S, Iwata S, Hatano R, Komiya E, Dang NH, Iwao N, Ohnuma K, Morimoto C. Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains Biochem Biophys Res Commun. 2016 May 20;474(1):111-117. </a>_x000D_ _x000D_ <strong>Products Related to Antibody to Human CD82 Conjugated to PE/Cy7 can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>